Dr. Ari Rosenberg, MD
Claim this profileUniversity of Chicago Comprehensive Cancer Center
Area of expertise
Squamous Cell Carcinoma
Ari Rosenberg, MD has run 13 trials for Squamous Cell Carcinoma. Some of their research focus areas include:
Head And Neck Cancers
Ari Rosenberg, MD has run 8 trials for Head and Neck Cancers. Some of their research focus areas include:
Affiliated Hospitals
University Of Chicago Comprehensive Cancer Center
University Of Chicago Medical Center
Clinical Trials Ari Rosenberg, MD is currently running
Zanzalintinib + Pembrolizumab + Cetuximab
for Head and Neck Cancer
This Phase I clinical trial evaluates the safety, tolerability, and optimal dosing of Zanzalintinib in combination with Pembrolizumab and Cetuximab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M HNSCC). The study aims to establish the maximally tolerated dose (MTD) and recommended Phase II dose (RP2D) while also exploring efficacy outcomes, including progression-free survival (PFS) and overall survival (OS).
Recruiting
1 award
Phase 1
6 criteria
Radiation Therapy + Cisplatin
for Head and Neck Cancer
This trial is studying if using a specific type of energy treatment alone or with a drug is better for treating patients with advanced head and neck cancer after surgery. The energy treatment kills cancer cells, and the drug helps by stopping their growth or killing them. The drug has been used for many years in the treatment of advanced cancers, including head and neck cancers, and is known for its ability to enhance the effects of the energy treatment.
Recruiting
1 award
Phase 2
19 criteria
More about Ari Rosenberg, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 17 trials as a Principal Investigator · 9 Active Clinical Trials
Treatments Ari Rosenberg, MD has experience with
- Carboplatin
- Paclitaxel
- Pembrolizumab
- Cetuximab
- Cisplatin
- Nivolumab
Breakdown of trials Ari Rosenberg, MD has run
Squamous Cell Carcinoma
Head and Neck Cancers
Head and Neck Squamous Cell Carcinoma
Throat Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ari Rosenberg, MD specialize in?
Ari Rosenberg, MD focuses on Squamous Cell Carcinoma and Head and Neck Cancers. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are Stage III.
Is Ari Rosenberg, MD currently recruiting for clinical trials?
Yes, Ari Rosenberg, MD is currently recruiting for 9 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Ari Rosenberg, MD has studied deeply?
Yes, Ari Rosenberg, MD has studied treatments such as Carboplatin, Paclitaxel, Pembrolizumab.
What is the best way to schedule an appointment with Ari Rosenberg, MD?
Apply for one of the trials that Ari Rosenberg, MD is conducting.
What is the office address of Ari Rosenberg, MD?
The office of Ari Rosenberg, MD is located at: University of Chicago Comprehensive Cancer Center, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.